Prevalence of anti-SARS-CoV-2 antibodies in Poznań, Poland, after the first wave of the COVID-19 pandemic
View ORCID ProfileDagny Lorent, Rafal Nowak, View ORCID ProfileCarolina Roxo, View ORCID ProfileElzbieta Lenartowicz, Aleksandra Makarewicz, Bartosz Zaremba, View ORCID ProfileSzymon Nowak, View ORCID ProfileLukasz Kuszel, Jerzy Stefaniak, View ORCID ProfileRyszard Kierzek, View ORCID ProfilePawel Zmora
doi: https://doi.org/10.1101/2021.03.29.21254544
Dagny Lorent
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Rafal Nowak
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Carolina Roxo
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Elzbieta Lenartowicz
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Aleksandra Makarewicz
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Bartosz Zaremba
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Szymon Nowak
2Department and Clinic of Tropical and Parasitic Diseases, Poznan University of Medical Sciences, Poznan, Poland
Lukasz Kuszel
3Department of Medical Genetic, Poznan University of Medical Sciences, Poznan, Poland
Jerzy Stefaniak
2Department and Clinic of Tropical and Parasitic Diseases, Poznan University of Medical Sciences, Poznan, Poland
Ryszard Kierzek
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Pawel Zmora
1Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
Data Availability
The manuscript contains all available data, which can be shown according to the Polish and European law.
Posted May 20, 2021.
Prevalence of anti-SARS-CoV-2 antibodies in Poznań, Poland, after the first wave of the COVID-19 pandemic
Dagny Lorent, Rafal Nowak, Carolina Roxo, Elzbieta Lenartowicz, Aleksandra Makarewicz, Bartosz Zaremba, Szymon Nowak, Lukasz Kuszel, Jerzy Stefaniak, Ryszard Kierzek, Pawel Zmora
medRxiv 2021.03.29.21254544; doi: https://doi.org/10.1101/2021.03.29.21254544
Prevalence of anti-SARS-CoV-2 antibodies in Poznań, Poland, after the first wave of the COVID-19 pandemic
Dagny Lorent, Rafal Nowak, Carolina Roxo, Elzbieta Lenartowicz, Aleksandra Makarewicz, Bartosz Zaremba, Szymon Nowak, Lukasz Kuszel, Jerzy Stefaniak, Ryszard Kierzek, Pawel Zmora
medRxiv 2021.03.29.21254544; doi: https://doi.org/10.1101/2021.03.29.21254544
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)